Market Price

68.55 

1.02 1.5%

as of May 14 '21

52 Week Range:

36.82 71.28


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 3.18
3.61
4.24
4.64
4.79
4.59
4.34
4.70
5.22
5.48
6.26
growth rate 13.5% 17.5% 9.4% 3.2% -4.2% -5.5% 8.3% 11.1% 5.0% 14.2%
Earnings BIT 150.10
145.50
138.30
124.60
155.90
182.60
207.80
235.60
275.20
316.60
266.10
growth rate -3.1% -5.0% -9.9% 25.1% 17.1% 13.8% 13.4% 16.8% 15.0% -16.0%
Avg.PE 28.82
22.47
32.89
41.67
57.03
47.53
25.77
61.10
52.95
52.95
52.95
growth rate -22.0% 46.4% 26.7% 36.9% -16.7% -45.8% 137.1% -13.3% 0.0% 0.0%
ROA 7.01
5.66
4.35
4.17
2.94
5.65
8.68
4.18
8.82
8.05
5.42
growth rate -19.3% -23.1% -4.1% -29.5% 92.2% 53.6% -51.8% 111.0% -8.7% -32.7%
ROE 20.26
16.11
11.67
10.32
7.03
13.62
21.75
11.13
22.16
21.87
16.90
growth rate -20.5% -27.6% -11.6% -31.9% 93.7% 59.7% -48.8% 99.1% -1.3% -22.7%
ROIC 14.26
11.01
8.76
7.86
5.58
10.53
15.77
7.87
15.70
13.72
9.06
growth rate -22.8% -20.4% -10.3% -29.0% 88.7% 49.8% -50.1% 99.5% -12.6% -34.0%
Cur. Ratio 1.26
1.58
1.92
2.21
2.34
2.22
2.43
2.59
2.18
2.78
2.43
growth rate 25.4% 21.5% 15.1% 5.9% -5.1% 9.5% 6.6% -15.8% 27.5% -12.6%
Quick Ratio 0.56
0.70
0.88
1.15
1.35
1.27
1.42
1.45
1.13
1.62
1.35
growth rate 25.0% 25.7% 30.7% 17.4% -5.9% 11.8% 2.1% -22.1% 43.4% -16.7%
Leverage 2.95
2.75
2.63
2.35
2.43
2.38
2.63
2.69
2.37
3.06
3.17
growth rate -6.8% -4.4% -10.7% 3.4% -2.1% 10.5% 2.3% -11.9% 29.1% 3.6%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 232.90
294.30
295.10
317.30
293.20
234.70
243.90
319.30
383.10
406.10
377.10
growth rate 26.4% 0.3% 7.5% -7.6% -20.0% 3.9% 30.9% 20.0% 6.0% -7.1%
Acct.Payable 352.10
343.80
350.10
76.00
72.10
86.10
90.80
104.50
118.40
134.60
growth rate -2.4% 1.8% -78.3% -5.1% 19.4% 5.5% 15.1% 13.3% 13.7%
Cur.Assets 1,051.10
1,194.10
1,309.70
1,431.90
1,366.30
1,231.50
1,275.90
1,358.80
1,304.30
1,796.30
1,925.00
growth rate 13.6% 9.7% 9.3% -4.6% -9.9% 3.6% 6.5% -4.0% 37.7% 7.2%
Total Assets 1,549.80
1,710.50
1,856.40
1,988.30
1,864.80
1,730.00
1,808.40
1,948.50
2,128.60
2,771.50
3,049.00
growth rate 10.4% 8.5% 7.1% -6.2% -7.2% 4.5% 7.8% 9.2% 30.2% 10.0%
Cash 230.40
246.00
310.60
438.70
319.50
267.10
342.40
325.00
322.40
678.30
681.80
growth rate 6.8% 26.3% 41.2% -27.2% -16.4% 28.2% -5.1% -0.8% 110.4% 0.5%
Inventory 511.00
576.20
611.50
589.80
477.40
422.00
440.40
486.20
509.60
577.20
692.30
growth rate 12.8% 6.1% -3.6% -19.1% -11.6% 4.4% 10.4% 4.8% 13.3% 19.9%
Cur.Liabilities 831.50
755.80
681.80
648.60
582.70
554.50
524.70
524.50
599.30
645.60
791.90
growth rate -9.1% -9.8% -4.9% -10.2% -4.8% -5.4% 0.0% 14.3% 7.7% 22.7%
Liabilities 1,025.10
1,089.00
1,149.80
1,142.20
1,093.10
997.10
1,115.30
1,215.00
1,200.90
1,833.30
2,074.70
growth rate 6.2% 5.6% -0.7% -4.3% -8.8% 11.9% 8.9% -1.2% 52.7% 13.2%
LT Debt 86.60
219.40
335.90
354.30
354.20
265.20
391.60
414.30
315.50
828.60
896.90
growth rate 153.4% 53.1% 5.5% 0.0% -25.1% 47.7% 5.8% -23.9% 162.6% 8.2%
Equity 524.70
621.50
706.60
846.10
765.90
726.10
686.40
725.40
896.60
906.80
961.20
growth rate 18.5% 13.7% 19.7% -9.5% -5.2% -5.5% 5.7% 23.6% 1.1% 6.0%
Common Shares 165.00
167.00
167.00
169.00
170.00
169.00
162.00
159.00
157.00
156.00
154.00
growth rate 1.2% 0.0% 1.2% 0.6% -0.6% -4.1% -1.9% -1.3% -0.6% -1.3%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 29.20
61.60
72.80
50.30
33.80
34.20
37.10
43.70
49.20
73.00
97.20
growth rate 111.0% 18.2% -30.9% -32.8% 1.2% 8.5% 17.8% 12.6% 48.4% 33.2%
Cash Dividends 0.10
0.40
0.60
0.60
25.80
25.80
25.80
25.40
25.10
25.00
24.60
growth rate 300.0% 50.0% 0.0% 4,200.0% 0.0% 0.0% -1.6% -1.2% -0.4% -1.6%
Cash From OA 156.10
87.70
133.10
145.00
114.30
229.20
130.80
154.40
239.70
213.40
332.20
growth rate -43.8% 51.8% 8.9% -21.2% 100.5% -42.9% 18.0% 55.3% -11.0% 55.7%
FCF per Share 0.75
0.24
0.36
0.23
0.83
0.70
0.93
0.61
1.08
0.92
1.09
growth rate -68.0% 50.0% -36.1% 260.9% -15.7% 32.9% -34.4% 77.1% -14.8% 18.5%
Sale Purchase of Stock 2.90
3.90
7.60
8.20
10.80
11.50
20.00
8.50
-131.40
-123.20
growth rate 34.5% 94.9% 7.9% 31.7% 6.5% 73.9% -57.5% -100.0% 0.0%
FCF 124.00
33.00
60.00
95.00
81.00
195.00
94.00
111.00
191.00
140.00
235.00
growth rate -73.4% 81.8% 58.3% -14.7% 140.7% -51.8% 18.1% 72.1% -26.7% 67.9%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 1,304.90
1,651.70
1,791.40
1,839.40
1,808.90
1,623.80
1,611.30
1,765.90
1,895.60
2,072.60
1,987.50
growth rate 26.6% 8.5% 2.7% -1.7% -10.2% -0.8% 9.6% 7.3% 9.3% -4.1%
Op.Income 155.70
92.30
77.50
80.10
155.90
182.60
207.80
235.60
275.20
316.60
266.10
growth rate -40.7% -16.0% 3.4% 94.6% 17.1% 13.8% 13.4% 16.8% 15.0% -16.0%
IBT 150.10
145.50
138.30
124.60
101.30
128.00
177.60
197.80
244.70
280.40
225.80
growth rate -3.1% -5.0% -9.9% -18.7% 26.4% 38.8% 11.4% 23.7% 14.6% -19.5%
Net Income 95.40
92.30
77.50
80.10
56.70
101.60
153.60
78.60
179.70
197.20
157.80
growth rate -3.3% -16.0% 3.4% -29.2% 79.2% 51.2% -48.8% 128.6% 9.7% -20.0%
EPS 0.58
0.55
0.46
0.48
0.33
0.60
0.95
0.49
1.14
1.26
1.02
growth rate -5.2% -16.4% 4.4% -31.3% 81.8% 58.3% -48.4% 132.7% 10.5% -19.1%
Gross Profit 604.00
752.50
829.40
805.20
788.30
729.80
756.30
821.60
906.50
1,012.80
944.40
growth rate 24.6% 10.2% -2.9% -2.1% -7.4% 3.6% 8.6% 10.3% 11.7% -6.8%
R&D 141.40
177.20
195.30
190.50
174.20
145.70
147.90
161.60
173.40
187.70
198.00
growth rate 25.3% 10.2% -2.5% -8.6% -16.4% 1.5% 9.3% 7.3% 8.3% 5.5%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 117.70
17.80
37.80
84.70
125.90
growth rate -84.9% 112.4% 124.1% 48.6%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 362.20
366.20
371.10
378.10
377.10
growth rate 1.1% 1.3% 1.9% -0.3%
Acct.Payable 118.40
127.00
119.20
113.90
134.60
growth rate 7.3% -6.1% -4.5% 18.2%
Cur.Assets 1,796.30
1,990.00
1,957.20
1,826.10
1,925.00
growth rate 10.8% -1.7% -6.7% 5.4%
Total Assets 2,771.50
2,961.90
2,943.40
2,879.40
3,049.00
growth rate 6.9% -0.6% -2.2% 5.9%
Cash 678.30
795.50
746.80
567.10
681.80
growth rate 17.3% -6.1% -24.1% 20.2%
Inventory 577.20
625.50
665.40
695.90
692.30
growth rate 8.4% 6.4% 4.6% -0.5%
Cur.Liabilities 645.60
765.80
749.70
683.20
791.90
growth rate 18.6% -2.1% -8.9% 15.9%
Liabilities 2,316.40
2,037.30
2,036.80
1,916.70
2,074.70
growth rate -12.1% 0.0% -5.9% 8.2%
LT Debt 812.80
924.30
935.30
856.80
896.90
growth rate 13.7% 1.2% -8.4% 4.7%
Equity 906.80
915.60
897.40
952.10
961.20
growth rate 1.0% -2.0% 6.1% 1.0%
Common Shares 154.16
1.70
1.70
1.70
1.70
growth rate -98.9% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 28.20
30.50
20.30
17.60
28.80
growth rate 8.2% -33.4% -13.3% 63.6%
Cash Dividends -6.20
6.20
6.10
6.20
6.10
growth rate 100.0% -1.6% 1.6% -1.6%
Cash From OA 136.20
35.00
11.80
82.40
203.00
growth rate -74.3% -66.3% 598.3% 146.4%
Sale Purchase of Stock 2.80
-0.60
-48.70
-5.20
-68.80
growth rate -100.0% 0.0% 0.0% 0.0%
FCF 108.00
4.50
-8.50
64.80
174.20
growth rate -95.8% -100.0% 100.0% 168.8%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 581.70
424.00
424.60
511.40
627.50
growth rate -27.1% 0.1% 20.4% 22.7%
Op.Income 117.70
17.80
37.80
84.70
125.90
growth rate -84.9% 112.4% 124.1% 48.6%
IBT 111.00
13.50
31.30
75.30
105.70
growth rate -87.8% 131.9% 140.6% 40.4%
Net Income 68.60
10.50
24.10
54.30
68.90
growth rate -84.7% 129.5% 125.3% 26.9%
EPS
growth rate
Gross Profit 296.30
193.10
186.50
248.50
316.30
growth rate -34.8% -3.4% 33.2% 27.3%
R&D 46.70
48.50
44.10
48.30
57.10
growth rate 3.9% -9.1% 9.5% 18.2%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (58.67)

YOY Growth Grade:

E (33.21)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 52.95 51.93 20.17
EPS / Growth 16.1% 1.32 10.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 5.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 5.5% 10.5% 10.5%
Future PE 10.96 20.62 20.62
Future EPS 2.25 3.59 3.59
Value Price
MOS %
6.10
-91.1%
18.31
-73.3%
18.31
-73.3%
MOS Price 3.05 9.15 9.15
IRT 24.51 17.80 17.80

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.